(Q42999603)

12 November 2017

Genomic response to interferon-alpha in chimpanzees: implications of rapid downregulation for hepatitis C kinetics (English)

1 reference

12 November 2017

1 reference

Robert E Lanford

1

1 reference

12 November 2017

Bernadette Guerra

2

1 reference

12 November 2017

Helen Lee

3

1 reference

12 November 2017

Deborah Chavez

4

1 reference

12 November 2017

Kathleen M Brasky

5

1 reference

12 November 2017

Catherine B Bigger

6

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 May 2006

1 reference

12 November 2017

1 reference

12 November 2017

43

1 reference

12 November 2017

5

1 reference

12 November 2017

961-972

1 reference

Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity

12 November 2017

1 reference

The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I.

21 January 2018

1 reference

Monocyte chemoattractant protein-1 and CCR2 interactions are required for IFN-alpha/beta-induced inflammatory responses and antiviral defense in liver

21 January 2018

1 reference

A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling

21 January 2018

1 reference

A novel interferon regulatory factor family transcription factor, ICSAT/Pip/LSIRF, that negatively regulates the activity of interferon-regulated genes

21 January 2018

1 reference

Interferon consensus sequence-binding protein, a member of the interferon regulatory factor family, suppresses interferon-induced gene transcription

21 January 2018

1 reference

Natural history of hepatitis C

21 January 2018

1 reference

7 January 2021

Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome

1 reference

7 January 2021

Mechanism of action of interferon and ribavirin in treatment of hepatitis C

1 reference

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

7 January 2021

Hepatocellular carcinoma: recent trends in the United States

1 reference

7 January 2021

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

7 January 2021

New kinetic models for the hepatitis C virus

1 reference

7 January 2021

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

1 reference

7 January 2021

DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection

1 reference

7 January 2021

Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees

1 reference

7 January 2021

Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection

1 reference

7 January 2021

Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection.

1 reference

7 January 2021

Analysis of ISG expression in chronic hepatitis C identifies viperin as a potential antiviral effector

1 reference

7 January 2021

Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C.

1 reference

7 January 2021

Efficient initiation of HCV RNA replication in cell culture

1 reference

7 January 2021

Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons

1 reference

7 January 2021

Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line

1 reference

7 January 2021

Interferon-alpha2b secretion by adenovirus-mediated gene delivery in rat, rabbit, and chimpanzee results in similar pharmacokinetic profiles

1 reference

7 January 2021

Comparison of tamarins and marmosets as hosts for GBV-B infections and the effect of immunosuppression on duration of viremia

1 reference

7 January 2021

Protein ISGylation modulates the JAK-STAT signaling pathway

1 reference

7 January 2021

Immunoregulatory properties of ISG15, an interferon-induced cytokine

1 reference

7 January 2021

The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses

1 reference

7 January 2021

Control of antiviral defenses through hepatitis C virus disruption of retinoic acid-inducible gene-I signaling

1 reference

7 January 2021

Regulation of Interferon Regulatory Factor-3 by the Hepatitis C Virus Serine Protease

1 reference

7 January 2021

VISA is an adapter protein required for virus-triggered IFN-beta signaling

1 reference

7 January 2021

Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3

1 reference

7 January 2021

IPS-1, an adaptor triggering RIG-I- and Mda5-mediated type I interferon induction

1 reference

7 January 2021

Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus

1 reference

7 January 2021

Immune evasion by hepatitis C virus NS3/4A protease-mediated cleavage of the Toll-like receptor 3 adaptor protein TRIF

1 reference

7 January 2021

Expression of the CXCR3 ligand I-TAC by hepatocytes in chronic hepatitis C and its correlation with hepatic inflammation.

1 reference

7 January 2021

Cross-genotype immunity to hepatitis C virus

1 reference

7 January 2021

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

1 reference

7 January 2021

The transcriptome of HCV replicon expressing cell lines in the presence of alpha interferon

1 reference

7 January 2021

Transcriptional and posttranscriptional regulation of interferon-induced gene expression in human cells

1 reference

7 January 2021

1 reference

7 January 2021

Suppressor of cytokine signaling 1 regulates the immune response to infection by a unique inhibition of type I interferon activity

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.21167

1 reference

12 November 2017

1 reference